These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29391602)

  • 1. Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis.
    Park J; Kim J; Park B; Yang KM; Sun EJ; Tognon CE; Sorensen PH; Kim SJ
    Oncogene; 2018 Apr; 37(17):2270-2284. PubMed ID: 29391602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
    Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH
    Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular transformation and activation of the phosphoinositide-3-kinase-Akt cascade by the ETV6-NTRK3 chimeric tyrosine kinase requires c-Src.
    Jin W; Yun C; Hobbie A; Martin MJ; Sorensen PH; Kim SJ
    Cancer Res; 2007 Apr; 67(7):3192-200. PubMed ID: 17409427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.
    Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH
    J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
    Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
    Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
    Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
    Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.
    Chen S; Nagel S; Schneider B; Dai H; Geffers R; Kaufmann M; Meyer C; Pommerenke C; Thress KS; Li J; Quentmeier H; Drexler HG; MacLeod RAF
    Cell Oncol (Dordr); 2018 Feb; 41(1):93-101. PubMed ID: 29119387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages.
    Lannon CL; Sorensen PH
    Semin Cancer Biol; 2005 Jun; 15(3):215-23. PubMed ID: 15826836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
    Lynch RA; Etchin J; Battle TE; Frank DA
    Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1.
    Jiang Y; Yu M; Hu X; Han L; Yang K; Ba H; Zhang Z; Yin B; Yang XP; Li Z; Wang J
    Cell Death Differ; 2017 Apr; 24(4):660-671. PubMed ID: 28186502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
    Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
    Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFR-β-activated ACK1-AKT signaling promotes glioma tumorigenesis.
    Zhang J; Chen T; Mao Q; Lin J; Jia J; Li S; Xiong W; Lin Y; Liu Z; Liu X; Zhao H; Wang G; Zheng D; Qiu S; Ge J
    Int J Cancer; 2015 Apr; 136(8):1769-80. PubMed ID: 25257795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412.
    Chi HT; Ly BT; Kano Y; Tojo A; Watanabe T; Sato Y
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):87-92. PubMed ID: 23131561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis.
    Liu S; Yu X; Wang Q; Liu Z; Xiao Q; Hou P; Hu Y; Hou W; Yang Z; Guo D; Chen S
    J Microbiol Biotechnol; 2017 Oct; 27(10):1855-1866. PubMed ID: 28838224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
    Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
    Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
    Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
    Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.